ScreenerHero

GHG Global Hemp Group Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · globalhempgroup.com
0.0200CAD0.00%Mkt Cap: 353810 $P/E: —

Global Hemp Group Inc. engages in health and wellness, and industrial hemp businesses. The Industrial Hemp division primarily focuses on the environmental uses of hemp for construction and bio-energy sources for carbon-n…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.13BUSDP/E 24.9
TAK
Takeda Pharmaceutical Company Limited
$59.16BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.78BUSDP/E 65.4
GALD
Galderma Group AG
$43.33BUSDP/E 56.1
HLN
Haleon plc
$40.72BUSDP/E 18.9
SDZ
Sandoz Group AG
$34.23BUSDP/E 59.2
HLN
Haleon plc
$32.92BUSDP/E 19.1
ZTS
Zoetis Inc.
$30.20BUSDP/E 12.0
UTHR
United Therapeutics Corporation
$22.85BUSDP/E 19.1
VTRS
Viatris Inc.
$20.03BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.06BUSDP/E 110.0
NBIX
Neurocrine Biosciences, Inc.
$14.36BUSDP/E 20.7
IPN
Ipsen S.A.
$12.68BUSDP/E 22.9
ELAN
Elanco Animal Health Incorporated
$11.26BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.16BUSDP/E 27.7
KRK
Krka, d. d.
$8.71BUSDP/E 19.4
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S
$6.66BUSDP/E 11.8
ALKS
Alkermes plc
$6.73BUSDP/E 105.6
HIMS
Hims & Hers Health, Inc.
$6.55BUSD

Key Statistics

Company
Market Cap353.81K USD
Enterprise Value3.12M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.88M USD
Revenue/Share—
Last Price0.0200 CAD
Fiscal Year EndSep 2023
MR QuarterJun 2024
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA37953Y2033
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-715.37
EV/Revenue—
P/S—
P/B-0.08
EPS (TTM)-0.16
EPS (Forward)—
52W Range
—
52W High0.0200 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE44.63%
ROA-6034.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-71.62K USD
CapEx (TTM)269.66K USD
FCF Margin—
FCF Yield68.92%
Net Debt2.77M USD
Net Debt/EBITDA-634.37
Balance Sheet
Debt/Equity-0.12
Current Ratio0.02
Quick Ratio0.01
Book Value/Sh-0.25 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 28, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.24.29M
Float24.05M
Insiders6.01%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short316
Short (prev mo.)316
Technical
SMA 500.0200 (-0.0%)
SMA 2000.0200 (-0.0%)
Beta0.99
S&P 52W Chg16.45%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0200 CAD
BB Middle0.0200 CAD
BB Lower0.0200 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—